| Literature DB >> 29593640 |
Seung-Han Lee1,2, Sang-Hoon Kim1, Ji-Min Kim1, Alexander Andrea Tarnutzer3,4.
Abstract
BACKGROUND: Wernicke's encephalopathy (WE), a metabolic disorder due to thiamine deficiency, manifests with various neurological symptoms and signs. It has been known as a cause of vestibular dysfunction. Preliminary reports have proposed predominant involvement of the horizontal semicircular canals (HSCs).Entities:
Keywords: Wernicke encephalopathy; bilateral vestibulopathy; head-impulse test; thiamine deficiency; vestibulo-ocular reflex
Year: 2018 PMID: 29593640 PMCID: PMC5857915 DOI: 10.3389/fneur.2018.00141
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Demographical and clinical findings of five patients with WE.
| # | Age range (years) | Cause of WE | D/V | M/M | Op | G/S | SN | GEN | bHIT for HC | Thiamine (initial) | Abnormalities on brain MRI | Thiamine replacement | Recovery |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 66–70 | Alcohol | Y | Y | Partial bilateral 6th palsy | Y | UB | Y | CS/CS | 33.78 | T2/FLAIR lesions in MVN, PAG, MB, HT, medial thalamus | IV (1,500 mg/day for 3 days, then 250 mg/day for 4 days) followed by PO (thiamine HCL 30 mg/day for 22 months) | All symptoms resolved after 6 months (22 months F/U in total) |
| 2 | 66–70 | Gut OP/TPN | Y | Y | N | Y | N | Y | CS/CS | NA | FLAIR lesions in MB and atrophy of MB | PO (thiamine HCL 20 mg/day + benfotiamine 138.3 mg/day for ~5 years) | Not improved (~6 years F/U in total) |
| 3 | 36–40 | Alcohol | N | N | N | Y | N | Y | CS/CS | NA | FLAIR lesions in MB and PAG | IV (1,500 mg/day for 7 days), followed by PO (thiamine HCL 30 mg + benfotiamine 138.3 mg/day for 21 days), then (thiamine HCL 20 mg/day + fursultiamine 54.57 mg/day for 20 months) | G/S—persistent (2.5 years F/U in total); others—improved |
| 4 | 66–70 | Alcohol | N | Y | N | Y | N | Y | CS/CS | 56.17 | T2/FLAIR lesions in PAG, medial thalamus, MB; atrophy of MB | IV (750 mg for 7 days) → PO (thiamine HCL 90 mg + benfotiamine 138.3 mg for 3 months) → (thiamine HCL 40 mg/day + benfotiamine 138.3 mg/day for 7 months) | Mental, G/S—improved; memory, HIT—persisted during 9 months F/U |
| 5 | 46–50 | Alcohol | N | N | N | Y | UB | Y | CS/CS | 51.23 | NS | IV (600 mg/day for 10 days), followed by PO (thiamine HCL 90 mg/day + benfotiamine 138.3 mg/day for 1 month) | Complete |
| All | 58.2 (±15) | Alcohol ( | 2/5 | 3/5 | 1/5 | 5/5 | 2/5 | 5/5 | 5/5 | 47 (±11.7) | 4/5 | IV + PO ( | Complete ( |
.
.
bHIT, bedside head-impulse testing; CS, catch-up saccades; D/V, dizziness and/or vertigo; F, female, FLAIR, fluid-attenuated inversion recovery; GEN, gaze-evoked nystagmus; G/S, gait and station impair; HT, hypothalamus; IV, intravenous; M, male, M/M, memory impairment or mental change; MB, mammillary body; MVN, medial vestibular nucleus; N, no; NA, not available; NS, non-specific; Op, ophthalmoplegia; PAG, periaqueductal gray matter; PO, per oral; SN, spontaneous nystagmus; TPN, total parenteral nutrition; UB, upbeat nystagmus; WE, Wernicke’s encephalopathy; Y, yes; MRI, magnetic resonance image.
Findings of caloric irrigation and video-head-impulse testing (vHIT) in five patients with Wernicke’s encephalopathy.
| # | bHIT for HC | O-to-A (d) | T-to-C (d) | T-to-vHIT (d) | SPV on caloric irrigation (°/s) | vHIT | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RC | RW | LC | LW | RH | LH | RA | LA | RP | LP | CS (RH/LH) | CS (RA/LA) | CS (RP/LP) | |||||
| 1 | CS/CS | 8 | 4 | 4 | 4.3 | −3.0 | −4.6 | 1.6 | 0.82 | 0.83 | 0.76 | 0.86 | +/+ | −/− | −/− | ||
| 2 | CS/CS | 240 | 78 | 78 | 4.2 | −3.6 | −5.1 | 2.8 | 0.81 | 0.93 | 1.09 | 0.81 | +/+ | −/− | −/− | ||
| 3 | CS/CS | 90 | 2 | 2 | 7.7 | −5.4 | −10 | 9.1 | 0.88 | 0.90 | 1.08 | 1.00 | +/+ | −/− | −/− | ||
| 4 | CS/CS | 30 | 4 | 4 | 4.9 | −2.9 | −3.2 | 6.7 | 0.53 | 0.67 | 0.66 | 0.53 | +/+ | −/− | +/− | ||
| 5 | CS/CS | 1 | NA | 8 | NA | NA | NA | NA | 0.89 | 0.73 | 0.71 | 0.93 | 0.81 | −/+ | −/− | −/− | |
| Avg | NA | 73.8 ± 99.3 | 22.0 ± 37.3 | 19.2 ± 32.9 | 0.75 ± 0.14 | 0.81 ± 0.11 | 0.90 ± 0.19 | 0.80 ± 0.17 | NA | NA | NA | ||||||
.
.
.
bHIT, bedside head-impulse testing; CS, catch-up saccades; d, days; LA, limb ataxia; LC, left cold; LH, left horizontal canal; LP, left posterior canal; LW, left warm; NA, not available; O-to-A, onset to admission; RC, right cold; RW, right warm; RA, right anterior canal; RH, right horizontal canal; RP, right posterior canal; SPV, slow-phase velocity; T-to-C, treatment to caloric testing; T-to-vHIT, treatment to video-head-impulse testing.
Figure 1Brain magnetic resonance image (patient #1) studies (fluid-attenuated inversion recovery images) show bilateral symmetrical lesions (as marked by white arrows) in the medial vestibular nucleus (A), the periaqueductal region (B), around the hypothalamus and mammillary bodies (C), and the periventricular regions of the thalamus (D).
Figure 2Video head-impulse testing from the same patient as in Figure 1 (patient #1) 12 days after symptom onset illustrating semicircular canal impairment restricted to the horizontal canals. For each semicircular canal, individual eye velocity traces (in green) and head velocity traces (in red for assessing the right vestibular organ and in blue for assessing the left vestibular organ) are plotted against time (20 trials per canal were recorded). Note that eye velocity traces are inverted to allow for better visualization and comparison with the head velocity traces. Mean gain values (eye velocity/head velocity) are shown in the hexagonal plot in the center of the figure. Whereas green bars indicate normal gains, red bars refer to reduced gains.
Figure 3Video head-impulse testing from all five patients, showing the results from a single subject in one row. For each semicircular canal, individual eye velocity traces (in green) and head velocity traces (in red for assessing the right vestibular organ and in blue for assessing the left vestibular organ) are plotted against time. Note that eye velocity traces are inverted to allow for better visualization and comparison with the head velocity traces. While upbeat nystagmus was present at the time of vHIT recordings in patients #1 and #5, this did not result in an increased number of saccades on the traces or reduced gains.
Clinical and neuro-otologic findings in selected cases with Wernicke’s encephalopathy reporting vestibular function (data from literature review).
| # | Age (years), sex | Cause | V | D | H | M/M | Op | G/S | LA | SN | GEN | CPN | bHIT | Pur | Sac | CP | qHIT | B1 nmol/L | MRI | Replacement therapy | Recovery | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hor | Ver | |||||||||||||||||||||
| 1 | 63, F | TPN | Y | NA | N | Y | Y | Y | Y | NA | Y | NA | CS | Ab | Ab | Y | Ab | Ab | NA | Ab | IV (100 mg/day) | Par |
| 2 | 40, M | Alcohol | Y | NA | N | Y | Y | Y | Y | NA | Y | NA | CS | Ab | Ab | Y | Ab | Nr | NA | Nr | IV (dose NA) | Par |
| 3 | 50, F | Alcohol | N | NA | NA | N | N | Y | N | N | Y | NA | CS | NA | NA | Y | Ab | Nr | 88 | Nr | PO (100 mg/day) | NA |
| 4 | 60, M | G.byp/Vo | Y | Y | NA | N | Y | Y | N | N | Y | NA | CS | NA | NA | NA | Ab | Nr | 21 | Nr | IV (500 mg/day), then PO (100 mg/day) | N |
| 5 | 37, F | G.byp/Vo | N | NA | NA | N | N | Y | N | DB | Y | NA | CS | NA | NA | NA | Ab | Ab | 55 | NS | IV (500 mg/day), then PO (100 mg/day) | Par |
| 6 | 53, M | NA | Y | N | N | NA | NA | NA | Y | UB | Y | NA | CS | Ab | Ab | Y | NA | NA | NA | NA | NA | NA |
| 7 | 64, M | NA | Y | Y | N | NA | NA | NA | N | UB | Y | Y | CS | Ab | Ab | Y | Ab | Nr | NA | Ab | NA | NA |
| 8 | 45, F | NA | Y | Y | N | NA | NA | NA | N | N | Y | N | CS | NA | NA | Y | NA | NA | NA | NA | NA | NA |
| 9 | 62, M | NA | Y | N | N | NA | NA | NA | N | N | Y | N | Nr | Nr | Ab | Y | NA | NA | NA | NA | NA | NA |
| 10 | 55, F | Alcohol | N | NA | N | NA | Y | Y | NA | UB | Y | NA | CS | Ab | Ab | NA | Ab | Nr | NA | Ab | IV (dose NA) | NA |
| 11 | 64, M | TPN | Y | NA | N | NA | Y | Y | NA | NA | Y | NA | CS | NA | Ab | NA | Ab | Nr | NA | Ab | IV (600 mg for 3 days, then 200 mg for 5 days), then PO (100 mg/day) | Par |
| 12 | 45, F | Alcohol/Vo | NA | NA | NA | Y | NA | Y | NA | UB | Y | NA | CS | NA | NA | NA | Ab | Ab | ~30 | Ab | IV(500 mg/day) | Par |
| All | 53.2 (±9.7) | 8/11 | 3/5 | 0/8 | 3/6 | 5/7 | 8/8 | 3/9 | 5/9 | 12/12 | 1/3 | 11/12 | 5/6 Ab | 7/7 Ab | 7/7 | 9/9 Ab | 3/9 Ab | 48.5 (±30) | 5/9 Ab | 7/8 IV | 5/6 Par | |
.
.
Ab, abnormal; ap, apogeotropic nystagmus; bHIT, bedside head-impulse testing; B1, thiamine; CP, canal paresis tested by caloric test; CPN, central positional nystagmus; CS, catch-up saccades; D, diplopia; DB, downbeat; F, female; G. byp, gastric bypass; GEN, gaze-evoked nystagmus; G/S, gait or standing impair; H, hearing loss; Hor, horizontal canal; IV, intravenous; LA, limb ataxia; M, male; M/M, memory impair or mental change; MRI, magnetic resonance image; N, no; NA, not available; Nr, normal; NS, non-specific; Op, ophthalmoplegia; Par, partial recovery; PO, per oral; Pur, pursuit; qHIT, quantitative head-impulse testing (either video based or search-coil based); Sac, saccades; SN, spontaneous nystagmus; TPN, total parenteral nutrition; UB, upbeat; Ver, vertical canal; V, vertigo; Vo, vomiting; Y, yes.
VOR gains obtained by head-impulse testing (video-oculography or search-coils) in 11 patients (5 from our series and 6 from the literature review) with Wernicke’s encephalopathy.
| Test time relative to Tx | Method | VOR gains | ||||||
|---|---|---|---|---|---|---|---|---|
| RH | LH | RA | LA | RP | LP | |||
| # 1 | Post-Tx ~72 h | vHIT | 0.82 | 0.83 | 0.76 | 0.86 | ||
| # 2 | Post-Tx ~3 y | vHIT | 0.81 | 0.93 | 1.09 | 0.81 | ||
| # 3 | Post-Tx ~72 h | vHIT | 0.88 | 0.90 | 1.08 | 1.00 | ||
| # 4 | Post-Tx ~72 h | vHIT | 0.53 | 0.67 | 0.66 | 0.53 | ||
| # 5 | Post-Tx ~144 h | vHIT | 0.89 | 0.73 | 0.71 | 0.93 | 0.81 | |
| # 1 | NA | Search coils | 0.84 | 0.66 | 0.72 | 0.8 | ||
| # 2 | NA | Search coils | 0.76 | 0.7 | 0.85 | 0.86 | ||
| # 7 | NA | Search coils | 0.91 | 0.93 | 0.67 | 0.67 | ||
| # 10 | Post-Tx ~24 h | Search coils | 0.81 | 0.72 | 0.99 | 1.16 | ||
| # 11 | Post-Tx ~4 m | vHIT | 0.86 | 0.84 | 0.82 | 0.84 | ||
| # 12 | Pre-Tx | vHIT | 0.75 | 0.55 | 0.13 | |||
| # 12 | Post-Tx 72 h | vHIT | 0.93 | 0.51 | 0.78 | 0.95 | ||
.
h, hours; LA, limb ataxia; LH, left horizontal canal; LP, left posterior canal; m, months; NA, not available; RA, right anterior canal; RH, right horizontal canal; RP, right posterior canal; Tx, treatment; vHIT, video-head-impulse testing; y, years.